KESTRA MED TECHNOLOG (KMTS) is drawing unusual attention today. Our newswire has captured 1 story on KMTS across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
Kestra Medical Technologies (KMTS) fell 9.60% to $21.75 in early trading on September 15, 2026, following a mixed earnings report and pre-market insider sales. The stock opened with a 9.9% gap down from the previous close of $24.06 and has traded in a narrow range since. The move reflects investor concerns over the company's continued losses and recent selling by directors.
Kestra Medical reported first-quarter FY 2027 results that showed a GAAP loss per share of $0.75, missing the consensus estimate of $0.62. Revenue of $31 million exceeded expectations by $1.99 million and rose 59.8% year-over-year. The company raised its full-year 2027 revenue guidance to $141 million from $137 million, while maintaining a target of mid-70% gross margins. Despite these updates, the stock fell sharply in pre-market trading. The Fly reported that Kestra’s shares were down 7% at $22.32 after the earnings miss.
On September 8, three directors, Hanley Conor, Schwartz Jeffrey Lawrence, and Reilly Kevin C, sold shares in the company. The Fly also noted that Kestra’s stock was down 7% in pre-market trading, and Benzinga highlighted the stock as one of several big movers in the session.
Kestra Medical’s stock opened at $21.69 and reached an intraday high of $22.05 before retreating to $21.32. The last traded price was $21.75. Volume was 0.0 million shares, or 0.1 times the 3-month average. The stock has declined 6.5% over the last eight sessions, from $25.73 to $24.06. Over the past 90 days, insiders have sold 17 times, totaling $6.5 million. The 52-week range is $17.34 to $30.00. On September 14, the stock printed two fresh 52-week lows.
Kestra Medical’s next key event is its earnings call transcript availability, which was released on September 14. Investors should monitor coverage breadth and any follow-up analyst commentary on the updated guidance and earnings performance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
KIRKLAND, Wash., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming...
KESTRA MED TECHNOLOG (KMTS) is drawing unusual attention today. Our newswire has captured 1 story on KMTS across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 53/100). The most recent driver: "Kestra Medical Technologies to Participate in Upcoming Investor Conferences" (Business Insider).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of KMTS coverage reads 53/100 over 1 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on KMTS: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier KMTS move explainers: 2026-09-15